
Researchers at Mayo Clinic in Florida are building a case that says neurodegenerative disorders like Alzheimer’s disease are primarily caused by genes that are too active or not active enough, rather than by harmful gene mutations. “If we can identify the genes linked to a disease that are too active or too dormant, we might be able to define new drug targets and therapies. That could be the case for both neurodegenerative disease as well as disease in general.” says lead investigator Nilufer Taner, M.D., Ph.D., a Mayo Clinic neurologist and neuroscientist.
For more information read news release: Dr. Taner New Risk Factors
The holiday season can invite unwelcome guests into your life, such as loneliness, money problems, family demands and unrealistic expectations. The stress and anxiety that ...
National Handwashing Awareness Week will be observed Dec. 3–9, so this is a good time for a reminder that washing your hands is one of the ...
The Food and Drug Administration is expected to decide by Dec. 8 on a new therapy to treat sickle cell disease using gene editing technology called CRISPR, ...